ROCKET PHARMACEUTICALS, INC. Annual Return On Assets in % from 2015 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Rocket Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from 2015 to 2023.
  • Rocket Pharmaceuticals, Inc. Return On Assets for the quarter ending September 30, 2024 was -54.2 %, a 14% decline year-over-year.
  • Rocket Pharmaceuticals, Inc. annual Return On Assets for 2023 was -45.9 %, a 3.8% increase from 2022.
  • Rocket Pharmaceuticals, Inc. annual Return On Assets for 2022 was -47.7 %, a 50.8% decline from 2021.
  • Rocket Pharmaceuticals, Inc. annual Return On Assets for 2021 was -31.6 %, a 6.5% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -45.9 +1.81 +3.8% Jan 1, 2023 Dec 31, 2023
2022 -47.7 -16.1 -50.8% Jan 1, 2022 Dec 31, 2022
2021 -31.6 +2.2 +6.5% Jan 1, 2021 Dec 31, 2021
2020 -33.8 -8.55 -33.8% Jan 1, 2020 Dec 31, 2020
2019 -25.3 +8.95 +26.2% Jan 1, 2019 Dec 31, 2019
2018 -34.2 -12.1 -54.6% Jan 1, 2018 Dec 31, 2018
2017 -22.1 -15.7 -246% Jan 1, 2017 Dec 31, 2017
2016 -6.39 +73.4 +92% Jan 1, 2016 Dec 31, 2016
2015 -79.8 Jan 1, 2015 Dec 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.